Airain Ltd’s Avadel Pharmaceuticals AVDL Stock Holding History

Airain Ltd’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-19,048	Closed	-$404K	–	839
2015 Q2	$404K	Buy	+19,048	New	+$342K	0.02%	573

Other funds holding AVDL

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Airain Ltd's AVDL Position: Q3 2015 in Review

Airain Ltd sold out of Avadel Pharmaceuticals (AVDL) in Q3 2015, closing a stake of 19,048 shares — an estimated $404K sold.

Airain Ltd first reported a position in AVDL in Q2 2015 and held it in 1 quarter. The position peaked at $404K in Q2 2015. 97 funds tracked by Wall St. Rank hold AVDL as of Q3 2015.

Airain Ltd reported no remaining Avadel Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
Airain Ltd sold 19,048 Avadel Pharmaceuticals shares in Q3 2015, an estimated $404K.
Airain Ltd first reported a position in Avadel Pharmaceuticals in Q2 2015 and held it in 1 quarter.
Airain Ltd's Avadel Pharmaceuticals position peaked at $404K in Q2 2015.
97 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q3 2015.

Based on Airain Ltd's 13F filing for Q3 2015, filed 9 Nov 2015.